Article citations

    Schwellnus, M., Soligard, T., Alonso, J.M., Bahr, R., Clarsen, B., Dijkstra, H.P., Gabbett, T.J., Gleeson, M., Hägglund, M., Hutchinson, M.R. and van Rensburg, C.J. (2016) How Much Is Too Much? (Part 2) International Olympic Committee Consensus Statement on Load in Sport and Risk of Illness. British Journal of Sports Medicine, 50, 1043-1052.
    https://doi.org/10.1136/bjsports-2016-096572

has been cited by the following article:

  • TITLE: Evaluation of ColdZyme Mouth Spray for the Protection against Common Cold in Elite Athletes to Reduce Unwanted Absence from Training and Competition
  • AUTHORS: Mats Clarsund
  • KEYWORDS: Common Cold, Athletes, ColdZyme<sup>®</sup> Mouth Spray
  • JOURNAL NAME: Open Journal of Respiratory Diseases DOI: 10.4236/ojrd.2017.73010 Jun 19, 2017
  • ABSTRACT: This study evaluated the protective effect of ColdZyme on common cold infections in elite athletes from three different sports (biathlon, ice-hockey and handball), and assessed the level of reduction in corresponding sick days. The biathlon team (n = 11) and the ice-hockey team (n = 29) significantly reduced the average number of sick days by 51% respectively 67% compared to historical data. No historical data on sick days was available for the handball team but 76% of those who experiences a cold during the study period reported little or very little impact on training and competition. Conclusion: Using ColdZyme may be an easy and practical way for elite athletes to protect themselves against the common cold and to prevent corresponding unwanted absence from training and competition.